High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.
Roberge M, Berlinck RG, Xu L, Anderson HJ, Lim LY, Curman D, Stringer CM, Friend SH, Davies P, Vincent I, Haggarty SJ, Kelly MT, Britton R, Piers E, Andersen RJ.
Roberge M, et al. Among authors: andersen rj.
Cancer Res. 1998 Dec 15;58(24):5701-6.
Cancer Res. 1998.
PMID: 9865726